Cargando…

Comments on COVID-19 Vaccination and Exacerbation of Idiopathic Pulmonary Fibrosis

Detalles Bibliográficos
Autores principales:	Kang, Tianlun, Hou, Xiujuan, Chen, Chih-Wei, Xi, Yajing, Wei, James Cheng-Chung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Thoracic Society 2022
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9799273/ https://www.ncbi.nlm.nih.gov/pubmed/35612926 http://dx.doi.org/10.1164/rccm.202205-0877LE

Ejemplares similares

Postvaccination Acute Exacerbations of Idiopathic Pulmonary Fibrosis?
por: Huang, Jin-Xian, et al.
Publicado: (2022)

COVID-19 Vaccine in Patients with Exacerbation of Idiopathic Pulmonary Fibrosis
por: Sgalla, Giacomo, et al.
Publicado: (2022)

Comment on Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults
por: Scholand, Mary Beth, et al.
Publicado: (2022)

Thrombomodulin Did Not Benefit Acute Exacerbation of Idiopathic Pulmonary Fibrosis in a Trial
por: Horita, Nobuyuki, et al.
Publicado: (2020)

Reply to Horita and Takeshi: Thrombomodulin Did Not Benefit Acute Exacerbation of Idiopathic Pulmonary Fibrosis in a Trial
por: Kondoh, Yasuhiro, et al.
Publicado: (2020)

Approach to acute exacerbation of idiopathic pulmonary fibrosis
por: Bhatti, Hammad, et al.
Publicado: (2013)

Acute Exacerbation of Idiopathic Pulmonary Fibrosis
por: Kishaba, Tomoo
Publicado: (2019)

Acute Exacerbation of Idiopathic Pulmonary Fibrosis
por: Lee, Joyce S., et al.
Publicado: (2013)

Acute Exacerbation of Idiopathic Pulmonary Fibrosis
por: Lee, Joyce S., et al.
Publicado: (2018)

Acute Exacerbation of Idiopathic Pulmonary Fibrosis
por: Kim, Dong Soon
Publicado: (2022)

Hematopoietic and Lung Platelet Biogenesis as a Prognostic Indicator in Idiopathic Pulmonary Fibrosis
por: Saito, Shigeki, et al.
Publicado: (2022)

Comparing Transbronchial Cryobiopsy and Surgical Biopsy in Idiopathic Pulmonary Fibrosis
por: Quadrelli, Silvia, et al.
Publicado: (2019)

Acute exacerbations in patients with idiopathic pulmonary fibrosis
por: Kim, Dong Soon
Publicado: (2013)

Asymmetry in acute exacerbation of idiopathic pulmonary fibrosis
por: Sokai, Akihiko, et al.
Publicado: (2017)

Acute Exacerbations in Patients With Idiopathic Pulmonary Fibrosis
por: Kim, Dong Soon
Publicado: (2018)

The Role of Infection in Acute Exacerbation of Idiopathic Pulmonary Fibrosis
por: Weng, Dong, et al.
Publicado: (2019)

Patient Registries in Idiopathic Pulmonary Fibrosis: Don't Forget Socioeconomic Status
por: Sesé, Lucile, et al.
Publicado: (2020)

Too Premature to Deny the Potential of Thrombomodulin Alfa in Idiopathic Pulmonary Fibrosis
por: Kobayashi, Tetsu, et al.
Publicado: (2020)

Measurement of hypoxia in the lung in idiopathic pulmonary fibrosis: a matter of control
por: Bellaye, Pierre-Simon, et al.
Publicado: (2022)

Idiopathic Pulmonary Fibrosis Update: Reconciliation with Hypersensitivity Pneumonitis Guidelines Required?
por: Moran-Mendoza, Onofre
Publicado: (2022)

Antifibrotics and Reduced Mortality in Idiopathic Pulmonary Fibrosis: Immortal Time Bias
por: Suissa, Samy, et al.
Publicado: (2022)

Construction of potential idiopathic pulmonary fibrosis related microRNA and messenger RNA regulatory network
por: Zhang, Yu-Feng, et al.
Publicado: (2021)

Coronavirus disease 2019 vaccination‐induced acute exacerbation in idiopathic pulmonary fibrosis
por: Sugino, Keishi, et al.
Publicado: (2022)

Pulmonary Hypertension Exacerbated by Nintedanib Administration for Idiopathic Pulmonary Fibrosis
por: Shimomura, Iwao, et al.
Publicado: (2018)

Collecting Occupational Exposure Data Would Strengthen Idiopathic Pulmonary Fibrosis Registries
por: Nett, Randall J., et al.
Publicado: (2020)

Identification of autophagy-related genes in idiopathic pulmonary fibrosis using bioinformatics methods
por: Sun, Shulei, et al.
Publicado: (2022)

Reply: Measurement of hypoxia in the lung in idiopathic pulmonary fibrosis: a matter of control
por: Porter, Joanna C., et al.
Publicado: (2022)

Macrophage Activation in Acute Exacerbation of Idiopathic Pulmonary Fibrosis
por: Schupp, Jonas Christian, et al.
Publicado: (2015)

Autopsy analyses in acute exacerbation of idiopathic pulmonary fibrosis
por: Oda, Keishi, et al.
Publicado: (2014)

Treatment with nintedanib for acute exacerbation of idiopathic pulmonary fibrosis
por: Tomioka, Hiromi, et al.
Publicado: (2017)

Risk factors for an acute exacerbation of idiopathic pulmonary fibrosis
por: Kakugawa, Tomoyuki, et al.
Publicado: (2016)

Acute exacerbations of idiopathic pulmonary fibrosis and the role of corticosteroids
por: Brereton, Christopher J., et al.
Publicado: (2020)

Acute exacerbation of idiopathic pulmonary fibrosis after SARS-CoV-2 vaccination
por: Bando, Tomohiro, et al.
Publicado: (2022)

Importance of Occupational Exposure Data: A National Idiopathic Pulmonary Fibrosis Registry Perspective
por: Teoh, Alan K. Y., et al.
Publicado: (2020)

No increased prevalence of autoantibodies neutralizing type I IFNs in idiopathic pulmonary fibrosis patients
por: Philippot, Quentin, et al.
Publicado: (2023)

Comments on Air Pollutant Exposures and COVID-19 Severity and Mortality: Some Concerns on Methodology
por: Chen, Hui-Yuan, et al.
Publicado: (2022)

Acute exacerbation of unclassifiable idiopathic interstitial pneumonia: comparison with idiopathic pulmonary fibrosis
por: Enomoto, Noriyuki, et al.
Publicado: (2020)

Isoniazid and Pulmonary Fibrosis
por: Chung, Chae Uk, et al.
Publicado: (2015)

Stimulator of Interferon Genes Deficiency in Acute Exacerbation of Idiopathic Pulmonary Fibrosis
por: Qiu, Hui, et al.
Publicado: (2017)

CD71(−) Alveolar Macrophages in Idiopathic Pulmonary Fibrosis: A Look beyond the Borders of the Disease
por: Puxeddu, Ermanno, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_bfv1lh0klbom7qg6bactj3kqg6